Otitis media-related antibiotic prescribing patterns, outcomes, and expenditures in a pediatric medicaid population
Treatment of otitis media is the most frequent reason for administering antibiotics to children in the United States. However, only limited data are available on medical effectiveness of antibiotic prescribing patterns for otitis media and their associated expenditures or the factors that influence...
Saved in:
Published in | Pediatrics (Evanston) Vol. 100; no. 4; p. 585 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.10.1997
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Treatment of otitis media is the most frequent reason for administering antibiotics to children in the United States. However, only limited data are available on medical effectiveness of antibiotic prescribing patterns for otitis media and their associated expenditures or the factors that influence antibiotic prescribing.
The study population consisted of 131 169 children during 1991 and 157 065 children during 1992 who were </=13 years of age and enrolled in Colorado's fee-for-service Medicaid program. Among these children, 5127 (1991) and 7254 (1992) were enrolled in the cohort treated for a "new" episode of acute otitis media. An analysis using this cohort was performed to document the antibiotics used to treat a new episode of acute otitis media, factors influencing antibiotic selection, and the short-term outcomes of therapy. An analysis using the entire Medicaid population was performed to document the annual use of antibiotics for otitis, the associated antibiotic expenditures, and factors influencing antibiotic selection.
In the cohort analysis, office-based physicians prescribed second- and third-generation cephalosporins more often than did physicians in other settings (17% vs 9.7% and 11.8%), whereas hospital clinics prescribed trimethoprim plus sulfamethoxazole more frequently than did office-based physicians (19.2% vs 7.1% and 10.9%). Family physicians prescribed second- and third-generation cephalosporins more often than did pediatricians (16.6% vs 12.3%) but trimethoprim plus sulfamethoxazole and erythromycin plus sulfisoxazole less often than did pediatricians (10.5% vs 17%). The average rate of prescribing a second course of antibiotics within 24 days after initial antibiotic treatment of a new acute otitis media episode was 11.6% when less expensive antibiotics (amoxicillin, trimethoprim plus sulfamethoxazole, or erythromycin plus sulfisoxazole) were prescribed, and 13.2% when more expensive antibiotics (cefaclor, amoxicillin plus clavulanate, or cefixime) were prescribed. The average adverse drug reaction rate was 5.9% when less expensive antibiotics were prescribed, compared with 6.1% when more expensive antibiotics were prescribed. In each of the two study years, amoxicillin accounted for almost half of the total antibiotic fills but only 9% to 10% of the expenditures. Low-cost antibiotics (amoxicillin, trimethoprim plus sulfamethoxazole, and erythromycin plus sulfisoxazole) were prescribed for 66% to 67% of the total fills and accounted for 21% of the total projected expenditures. More expensive antibiotics (cefaclor, cefixime, amoxicillin plus clavulanate) prescribed for 30% of the fills generated 76% to 77% of expenditures. Cefaclor, prescribed for 17% to 18% of the total fills, generated 43% to 45% of total antibiotic expenses.
The findings of this study document a preference for amoxicillin as the initial antibiotic for a new episode of acute otitis media. Although there was a wide variation in the selection of antibiotics to treat otitis, the more expensive antibiotics were not associated with better outcomes. This wide variation has important financial implications because of differences in antibiotic costs. Changes in prescribing patterns among initially uncomplicated children that reduce the use of high-cost antibiotics could reduce expenditures substantially without compromising short-term outcomes. |
---|---|
AbstractList | Treatment of otitis media is the most frequent reason for administering antibiotics to children in the United States. However, only limited data are available on medical effectiveness of antibiotic prescribing patterns for otitis media and their associated expenditures or the factors that influence antibiotic prescribing.
The study population consisted of 131 169 children during 1991 and 157 065 children during 1992 who were </=13 years of age and enrolled in Colorado's fee-for-service Medicaid program. Among these children, 5127 (1991) and 7254 (1992) were enrolled in the cohort treated for a "new" episode of acute otitis media. An analysis using this cohort was performed to document the antibiotics used to treat a new episode of acute otitis media, factors influencing antibiotic selection, and the short-term outcomes of therapy. An analysis using the entire Medicaid population was performed to document the annual use of antibiotics for otitis, the associated antibiotic expenditures, and factors influencing antibiotic selection.
In the cohort analysis, office-based physicians prescribed second- and third-generation cephalosporins more often than did physicians in other settings (17% vs 9.7% and 11.8%), whereas hospital clinics prescribed trimethoprim plus sulfamethoxazole more frequently than did office-based physicians (19.2% vs 7.1% and 10.9%). Family physicians prescribed second- and third-generation cephalosporins more often than did pediatricians (16.6% vs 12.3%) but trimethoprim plus sulfamethoxazole and erythromycin plus sulfisoxazole less often than did pediatricians (10.5% vs 17%). The average rate of prescribing a second course of antibiotics within 24 days after initial antibiotic treatment of a new acute otitis media episode was 11.6% when less expensive antibiotics (amoxicillin, trimethoprim plus sulfamethoxazole, or erythromycin plus sulfisoxazole) were prescribed, and 13.2% when more expensive antibiotics (cefaclor, amoxicillin plus clavulanate, or cefixime) were prescribed. The average adverse drug reaction rate was 5.9% when less expensive antibiotics were prescribed, compared with 6.1% when more expensive antibiotics were prescribed. In each of the two study years, amoxicillin accounted for almost half of the total antibiotic fills but only 9% to 10% of the expenditures. Low-cost antibiotics (amoxicillin, trimethoprim plus sulfamethoxazole, and erythromycin plus sulfisoxazole) were prescribed for 66% to 67% of the total fills and accounted for 21% of the total projected expenditures. More expensive antibiotics (cefaclor, cefixime, amoxicillin plus clavulanate) prescribed for 30% of the fills generated 76% to 77% of expenditures. Cefaclor, prescribed for 17% to 18% of the total fills, generated 43% to 45% of total antibiotic expenses.
The findings of this study document a preference for amoxicillin as the initial antibiotic for a new episode of acute otitis media. Although there was a wide variation in the selection of antibiotics to treat otitis, the more expensive antibiotics were not associated with better outcomes. This wide variation has important financial implications because of differences in antibiotic costs. Changes in prescribing patterns among initially uncomplicated children that reduce the use of high-cost antibiotics could reduce expenditures substantially without compromising short-term outcomes. |
Author | Byrns, P J Lezotte, D Smith, P J Berman, S Bondy, J |
Author_xml | – sequence: 1 givenname: S surname: Berman fullname: Berman, S organization: Department of Pediatrics, University of Colorado Health Sciences Center, Denver, Colorado, USA – sequence: 2 givenname: P J surname: Byrns fullname: Byrns, P J – sequence: 3 givenname: J surname: Bondy fullname: Bondy, J – sequence: 4 givenname: P J surname: Smith fullname: Smith, P J – sequence: 5 givenname: D surname: Lezotte fullname: Lezotte, D |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/9310510$$D View this record in MEDLINE/PubMed |
BookMark | eNotj09LAzEUxIMota1evQn5AO6abBI2OUrxHxR60XN5Sd5KpM2GJAv67d1iTzMPZn68WZHLOEYk5I6zlivZPSb0peWMtbJVWl2QJWdGN7Lr1TVZlfLNGJOq7xZkYQRnirMlKbsaaij0iD5Ak_EAFT2FWIMNYw2OpozF5fmKXzRBrZhjeaDjVN14xNlB9BR_EkYf6jRnaYgUaDrhap77J7CD4Gka0zTTwxhvyNUAh4K3Z12Tz5fnj81bs929vm-eto2TvamN1eg8N15wAYL3tlPOo0X0EjUO0Bs0OFhpGQgpFEgLwg3KoNbaccFMtyb3_9w02fmNfcrhCPl3fx7f_QFqAF_i |
CitedBy_id | crossref_primary_10_1016_j_clinthera_2004_12_016 crossref_primary_10_1016_j_jep_2015_11_014 crossref_primary_10_1007_s11882_010_0143_x crossref_primary_10_1007_s11882_011_0221_8 crossref_primary_10_5005_jp_journals_10057_0022 crossref_primary_10_1345_aph_1D052 crossref_primary_10_1093_pch_15_7_e14 crossref_primary_10_1097_01_inf_0000066242_21072_9d crossref_primary_10_1016_j_cpem_2013_04_005 crossref_primary_10_1542_peds_112_3_514 crossref_primary_10_3342_kjorl_hns_2015_58_12_848 crossref_primary_10_1007_BF01691129 crossref_primary_10_5409_wjcp_v5_i2_198 crossref_primary_10_1007_s11882_008_0095_6 crossref_primary_10_1186_1472_6963_10_193 crossref_primary_10_1291_hypres_31_1781 crossref_primary_10_1111_j_1524_4733_2007_00234_x crossref_primary_10_1542_peds_105_3_585 crossref_primary_10_1007_s11882_001_0050_2 crossref_primary_10_1367_1539_4409_2002_002_0293_TIOORI_2_0_CO_2 crossref_primary_10_1542_peds_2004_1473 crossref_primary_10_1002_pds_763 crossref_primary_10_1542_peds_112_3_527 crossref_primary_10_1177_000348940010900702 crossref_primary_10_1007_s41669_016_0007_y crossref_primary_10_1016_j_ijporl_2008_02_020 crossref_primary_10_1542_peds_102_1_157 crossref_primary_10_1542_peds_105_6_e72 crossref_primary_10_1542_peds_2007_1565 crossref_primary_10_1016_S1538_5442_01_70025_9 crossref_primary_10_1016_S1548_5315_11_70845_2 crossref_primary_10_1016_S1695_4033_00_77310_3 crossref_primary_10_1345_aph_19391 crossref_primary_10_1016_j_clinthera_2006_09_013 crossref_primary_10_1016_j_pedhc_2006_10_003 crossref_primary_10_1016_S0165_5876_01_00421_9 crossref_primary_10_1016_S1070_3241_02_28015_3 crossref_primary_10_1016_j_jhsa_2006_06_012 crossref_primary_10_1016_S0895_4356_01_00339_0 crossref_primary_10_1111_j_1600_0757_2008_00281_x crossref_primary_10_1097_00006454_199903000_00006 crossref_primary_10_1016_S0929_693X_00_88899_5 crossref_primary_10_1097_00006454_199904000_00013 crossref_primary_10_1542_peds_2003_0592_F crossref_primary_10_3928_0090_4481_19980201_03 crossref_primary_10_3928_0090_4481_19980201_04 crossref_primary_10_1211_ijpp_14_3_0008 crossref_primary_10_1542_peds_108_6_e102 crossref_primary_10_1007_s11882_008_0094_7 crossref_primary_10_1542_peds_104_S6_1192 crossref_primary_10_1097_MLG_0b013e31817924a3 crossref_primary_10_1046_j_1365_3016_2001_00326_x crossref_primary_10_1542_peds_113_5_1352 crossref_primary_10_1097_00006454_199808001_00005 crossref_primary_10_1542_peds_2005_2443 crossref_primary_10_1016_j_contraception_2013_07_004 crossref_primary_10_1177_00034894021110S312 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1542/peds.100.4.585 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1098-4275 |
ExternalDocumentID | 9310510 |
Genre | Research Support, U.S. Gov't, P.H.S Journal Article |
GeographicLocations | United States Colorado |
GeographicLocations_xml | – name: Colorado – name: United States |
GrantInformation_xml | – fundername: AHRQ HHS grantid: R01 HS07816-03 |
GroupedDBID | --- -ET ..I .55 .GJ 0R~ 123 18M 1CY 1HT 26- 29O 2KS 2QL 2WC 36B 39C 4.4 41~ 53G 5RE 5VS 6PF 7K8 85S 8F7 8GL 96U AAAMJ AAHTB AAIKC AAJMC AAKAS AAMNW AAQOH AAWTL AAWTO AAYOK ABCZD ABIVO ABJNI ABOCM ABPEJ ABPPZ ACBMB ACGFO ACGOD ACNCT ACPRK ADCOW ADZCM AENEX AFAZI AFFNX AFHKK AFOSN AFRAH AGFXO AHMBA AJUXI ALMA_UNASSIGNED_HOLDINGS BKOMP CGR CS3 CUY CVF DIK DU5 E3Z EBS ECM EIF EJD ESX EX3 F5P F8P FEDTE GICCO GOZPB GX1 H13 HF~ HVGLF IAG IAO ICJ IEA IER IGG IHR IHW IMI INH INR IOF IPO IPY ISE ITC IVC KO8 KQ8 L7B LXL LXN LXY N4W N9A NEJ NPM OHT OK1 OMK OVD P0W P2P PDE PQQKQ Q.- RHF RHI SJN TAE TEORI TR2 TWZ UBE UHB UMD W8F WH7 WHG WOQ WOW WQ9 X7M XJT XOL XZL YCJ YHG YHZ YOC YQI YQJ YZZ ZGI ZRR ZXP ~KM ~X8 |
ID | FETCH-LOGICAL-c479t-b8ecd19d313a317b25cdebeed4e8efa79e9efb4b0a3435a4ba3cf59e888c13092 |
IngestDate | Sat Sep 28 08:34:47 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c479t-b8ecd19d313a317b25cdebeed4e8efa79e9efb4b0a3435a4ba3cf59e888c13092 |
PMID | 9310510 |
ParticipantIDs | pubmed_primary_9310510 |
PublicationCentury | 1900 |
PublicationDate | 1997-10-01 |
PublicationDateYYYYMMDD | 1997-10-01 |
PublicationDate_xml | – month: 10 year: 1997 text: 1997-10-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Pediatrics (Evanston) |
PublicationTitleAlternate | Pediatrics |
PublicationYear | 1997 |
References | 9714642 - Pediatrics. 1998 Jul;102(1 Pt 1):157; author reply 157-8 |
References_xml | |
SSID | ssj0004572 |
Score | 1.8770906 |
Snippet | Treatment of otitis media is the most frequent reason for administering antibiotics to children in the United States. However, only limited data are available... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 585 |
SubjectTerms | Acute Disease Adolescent Amoxicillin - economics Amoxicillin - therapeutic use Anti-Bacterial Agents - economics Anti-Bacterial Agents - therapeutic use Cephalosporins - economics Cephalosporins - therapeutic use Child Child, Preschool Cohort Studies Colorado Drug Combinations Drug Costs Drug Utilization Erythromycin - economics Erythromycin - therapeutic use Female Humans Infant Male Medicaid Otitis Media - drug therapy Practice Patterns, Physicians' - statistics & numerical data Sulfisoxazole - economics Sulfisoxazole - therapeutic use Trimethoprim, Sulfamethoxazole Drug Combination - economics Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use United States |
Title | Otitis media-related antibiotic prescribing patterns, outcomes, and expenditures in a pediatric medicaid population |
URI | https://www.ncbi.nlm.nih.gov/pubmed/9310510 |
Volume | 100 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LTxsxELYCFRUXRHmoD0A-9BY2ZHftrH0kVSuEFMoBJG7Ir5U4NIma5EB_AL-bGdtxNuEh6GUV2ZvI2fl2PJ7HN4R8NyrvaclVBpuhy2CHcplkqpvVQjmrneK6h_XOg4ve2TU7v-E3rdZDI2tpNtUd8-_ZupL_kSqMgVyxSvYdkk0_CgPwGeQLV5AwXN8k49_INDQJ1R-Zr0pxyLyKZSAjJGLFJFfQCtpXnHsizWA1j2ZTWE5QEOg4R5p_DF3P_vr0rLZqj-cdPELwXd3Z9ji1-moatKnVh_feervcW5PJv9BH1b_sZO3fx3VcLoJS2N74fjlMlXw-cczGYr0qZbnB1hL0KdKVsiI0R0kKt9ttIIs11CcP7XueqHXOkCYW_voEszo6rLNyI4hl_McLWYK5ykOi7KuTKyTbcWaNrFUC9eQF-nwS53xVRLpPWMfJ8io2yUb87sq5xNsnV9tkKx4s6GlAySfScsMd8nEQUyd2ySSAhS6BhS7AQhtgoXOwHNM5VI7hVkubQKF3Q6poAgqdA4UugLJHrn_9vPpxlsWOG5lhlZxmWjhjc2nLvFRgWOqCGwtvubPMCVerSjrpas10V5VgZiumVWlqLp0QwoAxJIt9sj4cDd1nQotSwVG2p4XAQG5utBF1UVfMMauqXPMvZD88rttxoFW5jc_x60sT38jmAmMH5EMNb7E7BJNwqo-8xB4BXXNmJg |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Otitis+media-related+antibiotic+prescribing+patterns%2C+outcomes%2C+and+expenditures+in+a+pediatric+medicaid+population&rft.jtitle=Pediatrics+%28Evanston%29&rft.au=Berman%2C+S&rft.au=Byrns%2C+P+J&rft.au=Bondy%2C+J&rft.au=Smith%2C+P+J&rft.date=1997-10-01&rft.eissn=1098-4275&rft.volume=100&rft.issue=4&rft.spage=585&rft_id=info:doi/10.1542%2Fpeds.100.4.585&rft_id=info%3Apmid%2F9310510&rft_id=info%3Apmid%2F9310510&rft.externalDocID=9310510 |